The heart-based risk information was taken from colorectal cancer screening exams and beat out the Framingham risk score and body mass index.

The conference is moving "full steam ahead as scheduled" for March 9-13 in Orlando, but the list of vendors pulling out—which now includes Amazon and Siemens Healthineers—continues to grow amid coronavirus fears.

Radiologists should "become familiar" with the CT findings of COVID-19 and the shortcoming of chest radiographs when evaluating potential cases, researchers wrote in the Korean Journal of Radiology.

“This study shows a disheartening rate of inadequate exams among mpMRI studies of the prostate,” experts wrote in Academic Radiology.

Montefiore Medical Center has been running its pretreatment nuclear medicine clinic for 14 years, and its had an overwhelming impact on patients, according to a new study published in Current Problems in Diagnostic Radiology.

The Beloit, Wisconsin-based company has received exclusive rights from Capella Imaging to develop and investigate a new fibrin-targeted diagnostic agent that's used in heart imaging exams.

He will take the helm as the publication's editor-in-chief beginning in July, when longtime AJR Editor Thomas H. Berquist, MD, leaves for retirement, the American Roentgen Ray Society announced this month.

After weighing recommendations from local and global health agencies, the ESR determined it is not in a position to guarantee a safe congress for its attendees. The European Congress of Radiology will now take place July 15-19 in Vienna.

Radiologists must be mindful of the diverse imaging presentations of COVID-19, experts urged in a recent study.

These new recovery milestones will allow clinicians to pinpoint whether or not a patient is responding to therapy or making the necessary strides toward rehabilitation.

The discovery came after researchers combed through hundreds of brain scans and found that nearly 40% of patients did not have the reduced gray matter volumes typically seen in those with the disorder.

German scientists recently beat out 21 other projects in a three-year contest to improve the differential diagnosis of the disease.